関連する実験動画
Updated: May 5, 2026

09:20
CRISPR-Mediated Reorganization of Chromatin Loop Structure
Published on: September 14, 2018
14.2K
ポリコンブ抑制遺伝子には,再プログラムを開始する許容性増強剤があります
Phillippa C Taberlay1, Theresa K Kelly, Chun-Chi Liu
1Department of Urology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Cell
|December 14, 2011
まとめ
増強剤は,重要な調節遺伝子を活性化することによって,細胞運命を再プログラムする上で重要な役割を果たします. H3K4me1によって標識されたこれらの増強剤は,転写調節体の結合とクロマチンの変化を促進する核細胞欠乏領域を作り出します.
科学分野:
- エピジェネティクスと遺伝子調節
- 細胞の再プログラミング
- 分子生物学は分子生物学である.
背景:
- ポリコンブ群のタンパク質とH3K27me3メチレーションは,重要な調節遺伝子を抑制する.
- これらの遺伝子は,正常な分化と誘発された細胞再プログラミングの間に活性化されます.
- 強化剤は,遺伝子発現における重要な規制要素である.
研究 の 目的:
- モデルとしてMYOD1遺伝子を用いて,細胞運命を再プログラムする強化剤の役割を調査する.
- 再プログラミング中のエンハンサーにおける初期分子イベントを理解する.
- 異なる転写因子がプロモーターの染色体状態にどのように影響するか解明する.
主な方法:
- MYOD1遺伝子のエンハンサー/プロモーターペアの分析.
- クロマチンの分析,ヌクレオソーム枯渇とヒストンの改変プロフィール (H3K4me1,H3K27me3) を含む.
- 外因的なMyod1とOCT4を対象とした研究で,遺伝子転写とクロマチンの結合と効果を観察した.
主要な成果:
- 核素欠乏領域 (NDR) を有するH3K4me1強化剤が特定されました.
- トランスクリプションのレギュレータは最初はエンハンサーと結合し,プロモーターのクロマチンの変化を誘発する.
- エクソゲンなMyod1がエンハンサーに結合すると,NDRと許容性プロモータークロマチン経由で自身の転写が活性化されます.
- 増強剤への外因的なOCT4結合は,幹細胞の特徴であるプロモーターの二価なH3K27me3状態につながります.
結論:
- 増強剤は,転写レギュレータの結合を促進することによって,細胞の運命の再プログラムを開始するために重要である.
- MYOD1エンハンサーモデルは,エンハンサーがプロモータークロマチンの状態と遺伝子活性化をどのように制御するかを示しています.
- Polycombの標的の有意な割合は,許容性強化剤と関連しており,再プログラム開始のための広範なメカニズムを示唆しています.
関連する概念動画
RNA Polymerase II Accessory Proteins
8.9K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
8.9K
Co-activators and Co-repressors
7.0K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.0K
Combinatorial Gene Control
8.6K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.6K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Chromatin Modification in iPS Cells
1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
Methods of Nuclear Reprogramming
1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K

